Charles Schwab Investment Management Inc Pear Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.99 - $2.91 $4,898 - $14,398
4,948 Added 2.9%
175,689 $207,000
Q3 2022

Nov 14, 2022
BUY
$0.13 - $2.27 $19,610 - $342,431
150,851 Added 758.43%
170,741 $349,000
Q1 2022

May 13, 2022
BUY
$3.67 - $7.63 $72,996 - $151,760
19,890 New
19,890 $101,000

Others Institutions Holding PEAR

# of Institutions
2
Shares Held
23M
Call Options Held
0
Put Options Held
0
View Full List

About Pear Therapeutics, Inc.

PEAR Quotes by TradingView
  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email